Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative, Randomized Trial on HD-tDCS and Sham Control Group: Effects on Tinnitus Severity and Cognition Including Objective Measures.

NCT03754127 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT03754127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03754127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative, Randomized Trial on HD-tDCS and Sham Control Group: Effects on Tinnitus Severity and Cognition Including Objective Measures.
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
March 30, 2022
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus